A carregar...
Targeting minimal residual disease: a path to cure?
Therapeutics that block kinases, transcriptional modifiers, immune checkpoints and other biological vulnerabilities are transforming cancer treatment. As a result, many patients achieve dramatic responses, including complete radiographic or pathologic remissions, yet retain minimal residual disease...
Na minha lista:
| Publicado no: | Nat Rev Cancer |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6398166/ https://ncbi.nlm.nih.gov/pubmed/29376520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrc.2017.125 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|